"We need financial sustainability of HIV and TB services and their further integration into the national health systems".

The meeting concentrates on transitioning the programmes and services aimed at stopping the spread of HIV and tuberculosis to sustainable state funding (photo: Estonian Ministry of Social Affairs)

On December 1, an exhibition "B Positive" was opened in the America House Gallery in Kyiv within the social and cultural campaign for the World AIDS Day aimed to overcome public stereotypes towards people living with HIV.

The T-shirt chimes with the theme of this World AIDS Day campaign, #myrighttohealth. Everyone, regardless of who they are or where they live, has a right to health.

We believe that a better world for people living with HIV will mean a better world for everyone

HIV remains one of the continent’s most intractable health challenges. Tremendous progress is being made to understand the virus, the immune mechanisms that contribute to its control and for new antiretroviral drugs and vaccines to be developed to treat and prevent HIV. But much remains to ...

An 8-week course of sofosbuvir/ledipasvir (Harvoni) led to a sustained response in all people with HIV and genotype 1 or 4 hepatitis C virus (HCV) in the SWIFT-C study, according to a report at the AASLD Liver Meeting last month in Washington, DC.

The study shows that clinical interventions should take place at lower viral loads than those proposed by the current World Health Organization guidelines.

This report presents data on HIV and AIDS in 51 of 53 countries in the WHO European Region, and in the European Union and European Economic Area (EU/EEA).

The WHO European Region is the only region worldwide where the number of new HIV infections is rising. With more than 160 000 people newly diagnosed with HIV across the Region, including more than 29 000 new cases from the European Union and European Economic ...

The type of vaccine administered and the activation of the body's own immune cells influence the vaccine protection.

A second-line HIV regimen containing the integrase inhibitor raltegravir failed to meet its primary endpoint of noninferiority against standard second-line treatment with nucleoside reverse-transcriptase inhibitors, or NRTIs, according to 144-week data from the EARNEST trial.

Public Health England (PHE) has published its annual elimination of HIV and HIV testing reports for 2017.

The system of efficient and transparent public procurement is the Republic is not yet established.

More than 100 experts in the HIV/AIDS response area from all over the country convened at a round table in Bishkek (Kyrgyz Republic) on November 13 to discuss the issues of increasing access to medicines and ensuring the transparent functioning of medical institutions. The meeting ...

People with HIV taking antiretroviral treatment who had undetectable viral load did not suffer any loss of cognitive function or brain volume during a two-year period when compared with their HIV-negative peers, but did have lower cognitive function and brain volume at the start of ...

The round table with government officials, leading country and international experts in the area of HIV/IDS response on expand the availability of medicines and ensuring transparency of medical institutions is being held in Bishkek (Kyrgyz Republic) today. The event is organized by ECUO PLWH and the ...

Today in Chisinau a round table with government officials and leading domestic and international experts in HIV/AIDS was held.